# Lupin Limited – FDA Inspection, Jul 11, 2023

Source: https://www.keypedia.com/records/fda_inspections/lupin-limited/17123b34-eaa9-495e-b832-4865ddc69e72
Source feed: FDA_Inspections

> FDA inspection 1210103 of Lupin Limited, July 11, 2023. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 211. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1210103
- Company Name: Lupin Limited
- Inspection Date: 2023-07-11
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 4

## Related Documents

- FDA Inspection 1296412 - 2025-11-14
- FDA Inspection 1102191 - 2019-08-08
- FDA Inspection 1070260 - 2018-09-12
- FDA Inspection 1056627 - 2018-05-11
- FDA Inspection 1019497 - 2017-05-26

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/raquel-gonzalez-rivera/84cdd41f-b03c-4d13-a289-e2ebf4417c3c)
- [FDA Associated Person](https://www.keypedia.com/people/saundrea-a-munroe/129a869f-e1f2-4d59-b3ed-9613a9190f8a)

Company: https://www.keypedia.com/companies/lupin-limited/50f7d9dc-5597-42d6-b580-2154a13534ae

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
